on the omics integration analysis, where DNA methylation affects gene expression and genetic variants co-regulate gene expression and DNA methylation. We identified several threeway trans-association 'hotspots' that are found at the molecular level and that deserve further studies. Conclusions: The proposed integrative framework allowed us to identify relationships at the whole-genome level providing some new biological insights and highlighting the importance of integrating omics data.
the different types of omics data sets that are becoming available, since a single omics assessment provides limited insights into the understanding of the underlying biological mechanisms of a physiological/pathological condition. For example, even when many genome-wide association studies (GWAS) have identified several SNPs involved in complex diseases, the functional implications of the susceptibility loci are still poorly understood, and they only partially account for the phenotype variability. Combining different omics data types seems to be a more suitable approach, as it will likely reveal previously hidden information.
The simplest form of data integration involves the combination of two different data types, common examples being genetic variants and gene expression or, more recently, genetic variants and DNA methylation [1] . DNA methylation involves the addition of a methyl group to the 5 ′ position of the cytosine at a CpG site. Genomic regions with a high density of CpG dinucleotides are denominated CpG islands; they are often located in gene promoters and have important roles in gene regulation. CpG sites located up to 2 kb from the island's boundaries are called CpG shores, and it has been demonstrated that they are also very important for gene regulation and that they are implicated in cancer [2] . Both CpG islands and shores, when hypermethylated and located in the promoter region of a gene, negatively regulate gene repression [3] . Therefore, it is important to take the relationship between DNA methylation and gene regulation into account in order to better understand complex diseases [4] . For example, it has been shown that hypermethylation of CpGs located in the promoter region of some tumour suppressor genes ( INK4A , Rb , VHL , hMLH1 , or BRCA1 , etc.) contribute to cancer development [5] . Therefore, analyzing gene expression data without considering epigenetics provides an incomplete genomic explanation of the transcriptome. Moreover, as DNA methylation regulates gene expression, genetic variants affecting CpG sites might, in turn, affect gene expression, too. It is well known that genetic variants can alter gene expression levels and hence the importance of connecting the DNA sequence to the RNA level. The identification of these expression quantitative trait locus (eQTL) relationships may help to identify regulators of gene expression [6] . These eQTLs have been extensively studied to find associations between common genetic variants and gene expression levels [7] [8] [9] [10] [11] . By contrast, the study of potential associations between common variants, DNA methylation levels (methylation QTLs or methQTLs) and gene expression has generated less interest so far [1, [12] [13] [14] [15] .
Genome, transcriptome, and methylome data offer unique opportunities when combined in the same analyses. This strategy has been applied to HapMap cell lines [14] , whole blood from healthy human subjects [16] and human monocytes [17] . Furthermore, some studies have combined these types of data to better understand complex diseases such as breast cancer [18] or type 2 diabetes [19] . As DNA methylation is tissue-specific, these analyses have also been applied to different types of tissues such as the human brain [12] or adipose tissue [15] . It is worth noting that the majority of these studies have only assessed cis-relationships, but trans-effects deserve further study within the omics context, especially as the complex organization of chromatin in the nucleus is better understood.
In the present study, we built and propose a multistaged analytical framework to integrate omics data. We tested it on an urothelial bladder cancer (UBC) model using common genetic variants, DNA methylation and gene expression transcripts data from 70 cancer patients. We prove the ability of the framework to identify some multi-omics relationships that provide further knowledge to better understand the biological mechanisms underlying the disease.
Material and Methods
Study Subjects SNP genotypes, CpG methylation levels and gene expression levels were measured for a total of 70 individuals with fresh tumour tissue available who were recruited as part of the pilot phase of the EPICURO study. All of them were histologically confirmed UBC cases recruited at 2 hospitals in Spain during 1997-1998. Tumour DNA and RNA were extracted and used for omics assessment. SNP data were available for 46 patients, CpG methylation for 46 patients and gene expression for 43. The overlapping of patients between the three omics was 31 for the expression-methylation relationship, 27 for the eQTL and 46 for the methQTL studies.
SNP Genotype Data
Genotyping was performed using Illumina HumanHap 1M array in tumour samples. A total of 1,047,101 SNPs were genotyped in 46 individuals. For genotype calling, we used the cluster file obtained when the same array was applied to germline DNA from 2,424 subjects included in the main EPICURO study. We considered SNPs with <5% of missing values and with a minor allele frequency (MAF) of ≥ 0.01. Standard quality control (QC) was performed using BeadStudio and R. From BeadStudio, the genotypes AA, Aa and aa were obtained in forward strand for those samples having a call rate of >90%. 126 USA), CpG methylation data were generated using the Infinium Human Methylation 27 BeadChip Kit that detected the CpG sites with two probes, one designed against the unmethylated site (signal U) and the other against the methylated site (signal M). The level of methylation was determined at each locus by the intensity of the two possible fluorescent signals [20] . At each CpG site, the methylation levels were measured with the β value, defined as:
DNA Methylation Data
The maximum between signal intensity and 0 is used for the calculation of β to avoid the negative numbers caused by background subtractions. Consequently, the β values rank between 0 (unmethylated) and 1 (methylated). The constant 100 was used to regularize the β values when they were very small. Although the β values are useful under some circumstances, it has been demonstrated that the M values are statistically more valid than the β values due to a better approximation of the homocedasticity [21] . This property is important when applying regression models that require this assumption. The M value is calculated as follows:
It ranges between -∞ (unmethylated) and + ∞ (methylated). In our study, the M values were used when applying linear regression models, while the β values were used in the rest of the analyses. The initial number of CpGs in the studied array was 27,578. We then applied BeadStudio software and R to pre-process the data. Background normalization was performed minimizing the amount of variation in the background signals between arrays and, as recommended by Illumina, CpGs were rejected when their detection p value was >0.05. β values <0 or >1 were also excluded. CpGs with SNPs (n = 908) or cross-reactive probes (n = 2,985) were deleted based on earlier reports for the 27K array [22] . After QC, a total of 23,034 CpGs were kept for analysis. These were classified into 3 categories for subsequent analyses: CpG islands (located in the promoter region of a gene), CpG shores (in a sequence up to 2 kb from an island) and CpGs outside of an island or a shore.
Gene Expression Data
Gene expression data were obtained from 43 tumour samples using the Affymetrix DNA Microarray Human Gene 1.0 ST Array with 32,321 probes. This array was based on the 2006 (UCSC hg18, NCBI build 36) human genome sequence with coverage of RefSeq, Ensembl and putative complete CDS GenBank transcripts (www. affymetrix.com). QC was performed using Bioconductor libraries in R (www.bioconductor.org/). The arrayQualityMetrics package [23] was used to implement a background correction and to carry out normalization of expression levels across arrays. The application of QC steps resulted in 20,899 probes and 37 individuals. The affy library in R [24] was used to annotate the probes.
Statistical Analysis
First, tumoural DNA methylation levels in CpG sites and gene expression levels were compared using Spearman's rank correlation for non-normally distributed variables. Second, we assessed the eQTLs and methQTLs, via linear regression modelling for those expression-methylation pair probes that were strongly associated in the previous step. To perform these analyses, we obtained a linear regression model for each SNP as:
Prior to analysis, we excluded those SNPs that had <2 individuals per genotype due to the imbalance that may produce a highly differential gene expression values, i.e. an individual with rare homozygous genotype and with an extreme gene expression value could produce an artificially highly significant p value.
Expression-methylation probe pairs and eQTLs and methQTLs were classified into three categories according to possible genomic distance effects: cis-acting, if the probes were located within 1 Mb; trans-acting, if the probes were on the same chromosome but located more than 1 Mb apart, and trans-acting -outside, if they were on different chromosomes. To control the analyses for multiple testing, we applied Benjamini and Yekutieli's [25] FDR method that allows for panel dependencies between tests. We applied this correction, taking the number of tests performed in the eQTL and the methQTL study independently into account. Finally, we checked the regions of the trait-associated SNPs already published for UBC.
Third, in line with the study, we integrated the results obtained from pair-wise analyses on genome, epigenome and trascriptome data. We checked the SNPs that were common in the eQTL and methQTL analysis based on those probes-CpGs that were previously correlated in order to have a complete view of the genome in individuals with UBC. We obtained the distribution of the triplets (SNP-CpG-gene expression) that were significantly associated in the same relationship.
Statistical analyses were performed with R, and the results were visualized with Circos software [26] .
Results
The majority of the individuals included in our study were male (93%) and current (50%) or former (36%) smokers. According to established criteria based on tumour stage and grade for UBC, the individuals were classified as having low-risk non-muscle-invasive tumours (45%), high-risk non-muscle-invasive tumours (22%) or muscle-invasive tumours (29%) ( table 1 ).
The description of the study results is organized in four sections following the framework steps proposed ( fig. 1 ): (1) description of the patterns of individual omics data, globally and according to epidemiological data; (2) correlation analysis between methylation and expression probes; (3) identification of cis-and trans-eQTLs and methQTLs, and (4) integration of results derived from the previous pair-wise analysis. Table 2 shows the distribution of the genotypes according to their MAF; 14% had a MAF of 0 and were excluded from the analysis, 11% had a MAF of (0.01-0.05], 30% had a MAF of (0.05-0.2], and 31% had a MAF of (0.2-0.4]. Missing values of <5% were observed in 84% of the SNPs.
Patterns of Individual Omics Data
The patterns for DNA methylation according to the β and M values were different for autosomal chromosomes and X-chromosomes in females due to the X-chromosome inactivation in females. The majority (71%) of CpGs in autosomal chromosomes were unmethylated (β < 0.3), while, as expected, the majority of the CpGs (66%) in the X-chromosomes showed β values in the range of 0.3 ≤ β < 0.7. While the M values for autosomal chromosomes displayed a bimodal distribution, the X-chromosomes ap- fig. 1 ; see www.karger.com/doi/10.1159/000381184 for all online suppl. material). No significant different methylation patterns were found according to the clinical/epidemiological data considered, i.e. smoking status, tumour stage, age, and sex (Pearson's χ 2 test, data not shown). The expression of the gene probes after background correction and normalization followed a normal distribution (online suppl. fig. 2 ). We did not find any significant difference according to the clinical/epidemiological data by applying Student's t test (data not shown).
Correlation between Gene Expression and DNA Methylation
While it is well established that DNA methylation may affect the expression of a gene, mainly in a cis -relationship, little is known about trans -relationships . We investigated a total of 481,387,566 possible correlations between gene expression and methylation both in cis-and in trans -relationships. The number of comparisons performed was based on data derived from 31 individuals ( table 3 ) . We obtained 19,335 strong negative (ρ < -0.7) and 88,503 strong positive (ρ > 0.7) associations between gene expression and methylation, corresponding to 7,359 expression traits and 9,537 CpG sites. The distribution of the stronger relationships according to the CpG location and direction is shown in table 4 : 5,414 (28%) were located in CpG islands, 1,690 (59%) in CpG shores and 2,433 (57%) outside of CpG islands or shores. There were 
Identification of cis-and trans-eQTLs and methQTLs
In order to detect genetic variants affecting gene expression or DNA methylation, we investigated a total of 7,359 expression traits and 9,537 CpG sites that were strongly correlated in the previous step. The number of SNPs considered here after QC was 429,892 for the eQTL and 492,189 for the methQTL analyses, resulting in a total of 3,163,575,228 eQTLs in 27 individuals and 4,694,006,493 methQTLs explored in 46 individuals. After correction for multiple testing (FDR <0.05), we obtained 471,818 significant eQTLs involving 154,203 SNPs, and 643,095 methQTLs involving 148,528 SNPs. These results point to the fact that multiple expression probes and CpGs were significantly associated with more than one SNP. We refer to this phenomenon as 'hotspots' (online suppl. fig. 3 ).
We show the distribution of QTLs classified by genomic distance and MAF of the relationship for eQTLs in table 5 and for methQTLs in table 6 . When classifying the QTLs by genomic distance, we observed 441 cis-eQTLs (0.02%), 23,685 trans-eQTLs (0.01%) and 447,692 transout -eQTLs (0.01%); 538 cis-methQTLs (0.01%), 29,938 trans-methQTLs (0.01%), and 612,619 trans-outmethQTLs (0.01%). When classifying the QTLs in terms of MAF, the majority had a MAF of ≤ 0.2 (0.006%), while 0.003 and 0.002% had MAFs of (0.2-0.4] and ≥ 0.4, respectively. Detailed information regarding the cis-relationship is provided in online supplementary tables 2 and 3. When we checked how the significant findings are distributed in terms of the direction of the relationship, there were more QTLs positively than negatively associated (60 vs. 40% eQTL, 63 vs. 37% methQTLs), implying that having more copies of the rare allele increases the levels of the gene expression or the levels of methylation.
Lastly, for the QTL associations in our study, we investigated how many of the SNPs involved have been previously reported as a trait-associated SNPs for UBC. We found that SNP rs401681-TERT/CLPTM1L on chromosome 5 has been associated with the expression of FRMD6 located on chromosome 14 (p value = 3.7 × 10 -5 ), and with cg18368125-TMED6 on chromosome 16 (p value = 4.8 × 10 -5 ). Also, SNP rs1495741-NAT2 on chromosome 8 has been associated with the expression of C19orf73 located on chromosome 19 ( fig. 2 ) .
Integration of Results Derived from the Pair-Wise Analysis
From the final subset of eQTLs and methQTLs, we obtained 49,708 common SNPs (50% from the total SNPs for eQTLs and methQTLs), affecting a total of 227,572 eQTLs (207 cis-acting) and 298,869 methQTLs (247 cis-acting). Multiple expression probes and CpGs were significantly associated with more than one SNP and vice versa. We found that 1,469 QTLs belonged to a triple relationship (SNPCpG-gene expression; see online suppl. table 4). Regarding the association patterns, the majority (29%) of these 1,469 triplets showed a positive association pattern, i.e. the higher the methylation, the higher the expression, where the rare allele is classified with higher expression and methylation levels. A second pattern (19%) was 'the higher the methylation, the lower the expression', where the rare allele is associated with high expression levels and low methylation levels. When restricted to cis -relationship, no triplets were found, but there were 19 pairs (1 eQTL, 1 methQTL and 17 CpG-gene expression pairs) that were in cis . The distribution of these pairs was completely different from that of the rest of the triplets. The most frequent pattern (32%) observed was a positive association between SNPs and methylation and a negative association of both SNPs and CpGs with the expression. All of the possible patterns with their percentages are shown in table 7 . Lastly, we checked for the hotspots in these triplets and found some of them for SNPs, CpGs and gene expression probes ( fig. 3 ). TT (7) TC (14) CC ( The post-genome era delivers a wealth of omics data allowing to explore the relationships between genetics, epigenetics and gene expression, being of great importance to better understand the biological mechanism(s) underlying a disease. In the field of cancer, this integrative approach becomes particularly crucial on the basis of the knowledge indicating that SNPs, CpGs and gene expression play an important role in the development of these complex diseases [27, 28] .
In this work, we propose an omics integrative analytical framework based on a multi-staged strategy, and we apply it to explore the relationships between three sets of data measured at a genome-wide level in UBC tumour samples. We provide further evidence on how common genetic variation and DNA methylation are statistically associated with the regulation of gene expression. Based on the knowledge that DNA is looped, allowing the interaction between two DNA regions located far away from each other, we did not only study cis-but also trans-relationships [29] . Here, we showed that some SNPs are associated with DNA methylation, that the latter is associated with gene expression and that some SNPs associate with both DNA methylation and gene expression.
Individual and Pair-Wise Analyses
The global pattern for methylation observed in our study (online suppl. fig. 1 ) parallels that reported previously for germline (blood) [14] . Consistently with previous studies performed on blood [14, 16] and human brain samples [13] , we found that -when located in an island/ shore -the correlations between DNA methylation and gene expression from the same gene are predominantly negative, supporting the known biological mechanisms of gene regulation (80%). DNA methylation occurs near the transcription start site of a gene, blocking the initiation of gene expression (for a review, see Jones [3] ). To highlight the relevant results, four different CpGs (cg01354473, cg07778029, cg25047280, and cg26521404) located in a CpG island of the HOXA9 gene on chromosome 8 were negatively correlated with the expression of the gene. It was reported that HOXA9 acts as a tumour suppressor gene in oral cancer [30] , while methylation of this gene has been associated with the regulation of its expression in UBC [31] and with a risk of different cancers such as breast [32] , oral cavity [33] and ovarian cancer [34] as well as with a risk of recurrence in UBC [35] . The observed negative association between four CpGs and HOXA9 expression in our study suggests that the inhibition of HOXA9 expression may affect the development of UBC and supports the approach applied in this study.
On the other hand, the ENCODE Project provided some clues to the understanding of the biological behaviour of trans -relationships and of CpGs belonging to cisrelationships when located in a different gene [36] . In our study, we mainly observed positive correlations (79%) in all of these scenarios, meaning that increasing levels of methylation correlated with increasing levels of gene expression or the other way around, suggesting either a direct mechanism or an indirect mechanism, where methylation affects expression of a gene repressor, thus leading to an apparent association with increased gene levels. These results warrant further mechanistic studies explaining the complex association between DNA methylation and gene expression.
Little is known about the relationship between genetic variants and DNA methylation. Heyn et al. [1] has recently published a methQTL analysis using the cancer genome atlas data but only with SNPs detected in GWAS and cis -acting methQTLs. They detected one methQTL in UBC, where SNP rs401681 in TERT_CLPTM1L was associated with cg06550200 located in CLPTM1L ; unfortunately, we have not been able to replicate this association as this CpG is not present in the 27K methylation array. Nonetheless, for the first time, we have performed cis-and trans -acting methQTL analyses in UBC tumour tissue samples using CpGs that have previously been correlated with gene expression. From this assessment, we found 538 cis-relationships (listed in the online suppl. table 3 with all necessary information for further studies and validation). More frequently, cis -relationships between genetic variants and gene expression levels have been assessed. We also performed eQTL association studies in cis -and trans -relationships under the same conditions as for methQTLs and found 441 cis -eQTLs (online suppl. table 2). We performed these analyses on significant expression-methylation-correlated probes identified in the first step upon the assumption that epigenetics interferes with the gene expression levels.
The proportion of eQTLs (0.01%, 471,818) and methQTLs (0.01%, 643,477) was similar, although more SNPs were involved in eQTLs (32.6%, 154,203) than in methQTLs (22.7%, 148,528), possibly because of the smaller sample size of the former. Similarly, we found no major differences in the percentages of QTL associations classified as cis-, trans-and trans-out according to the genomic distances defined before. Nevertheless, when considering the MAF distribution, a higher number of QTLs were observed for SNPs with a MAF of ≤ 0.2. While these results should be interpreted cautiously, due to the possibility of false positives, it is worth highlighting that we found a greater number of positive than negative QTL relationships, meaning that having the rare allele is associated with increased gene expression or methylation levels.
Some studies have related SNPs associated with complex diseases at genome-wide significance level to gene expression or methylation levels [1, 10, 37] . Out of the 14 GWAS UBC SNPs [38] , 2 were shown to be associated with gene expression and methylation in trans -relationships ( fig. 2) . Interestingly, rs401681 -TERT/CPTL1M , a variant strongly associated with low-grade and low-risk UBC [38] , was found to be associated with a lower expression of FRMD6 in our study, a gene that was reported to be involved in the inhibition of proliferation in human cells [39] .
Integrative Analysis
We observed an enrichment of significant associations of genetic variants with methylation and gene expression with 49,708 SNPs related to 227,572 eQTLs and 298,869 methQTLs (207 eQTLs and 247 methQTLs in cis -relationship) suggesting a co-regulated expression and methylation. The percentage of enrichment associated with eQTLs (11.5%) and methQTLs (10.0%) was similar to that found by Wagner et al. [40] who detected an enrichment of 9.5% in fibroblasts. Bell et al. [14] also found an enrichment in lymphoblastoid cell lines. In contrast, Gibbs et al. [12] found only a modest overlap between both data in brain tissues, while Drong et al. [15] found no enrichment in adipose tissue. This highlights the fact that specific genetic variants may show tissue-specific effects and that little is known about them at a genomewide level.
We also found a total of 1,469 QTLs, where the same SNP was significantly associated with both eQTL and methQTL in previously identified significant gene expression-CpG pairs. This three-way type relationship between SNP-CpG-gene expression supports the notion that the three data sets implemented in this study are closely related in regulating part of the genome, an observation that may provide new insight into the genetics of this complex disease. Furthermore, we observed that the most frequent pattern (29%) in these three-way relationships is a positive association pattern, suggesting that hypermethylation may act through a direct mechanisms or affect a repressor gene associated with an over-expression of gene levels. In addition, having the rare allele is associated with hypermethylation and over-expression pattern. This finding together with the fact that, in our study, 82% of the CpGs that are related with gene expression in transeffect are positively correlated suggest that if one SNP is co-regulating both, this relation should be positive. Thus, we could hypothesize that the rare allele of the SNP associates with hypermethylation and, at the same time, associates with over-expression, as a possible regulation scenario in trans -effect.
When inspecting the cis -relationships, no triplets were found, but there were 19 pairs (1 eQTL, 1 methQTL and 17 CpG-gene expression pairs). In this scenario, the most frequent pattern (32%) suggests that having the rare allele is associated with hypermethylation and under-expression, where expression and methylation are associated inversely. This fact suggests another possible regulation scenario based on previous findings. We demonstrated that 79% of the CpGs located in the promoter region of the gene are negatively correlated in cis -relationships with the gene expression levels; meaning that higher methylation levels may effect a decrease in the gene expression levels. An example of this scenario is shown in figure 4 , where SNP rs289516 located in gene DLC1 is negatively associated in trans -relationship with the expression of HOXA9 (β = -1.1; p value = 3.7 × 10 -5 ) and positively with cg01354473 located in the island of the HOXA9 gene (β = 1.8; p value = 9.9 × 10 -5 ). The relationship between the expression and the methylation levels in the HOXA9 gene has already been reported as negatively correlated (r 2 = -0.7; p value = 1.4 × 10 -5
). It has been already published that the methylation of HOXA9 is negatively correlated with the gene expression in UBC [31] , as we observed in our study. We added a new step to this complex scenario, since SNP rs289516 is also involved in this triple relationship. This SNP belongs to the DLC1 gene considered as a tumoor suppressor gene, and this particular SNP has been picked up in two GWAS, one for asthma [41] and one for breast cancer [42] , but any of them passed the GWAS significant threshold. Other examples with biological support are the triplet composed by SNP rs29658399 located on gene DNAH11 , the gene expression of HSPA1A and cg00929855 located on gene HSPA1A . It has previously been published that the HSPA1A promoter methylation underlies the defect in gene expression reduction observed in UBC cell lines [43] . In addition we found some hotspots in these triplets regarding SNPs, CpGs and gene expressions probes.
In the Circos plot ( fig. 3 a) , we observed a predominant relation for one SNP (rs10569 located on gene PGM2 ) on chromosome 4. PGM2 is a protein-coding gene and is as-sociated with diseases such as pneumonia and hypoxia. While alterations in this gene have not yet been directly associated with cancer, hypoxia is a known relevant process for tumour survival. This SNP has been positively associated with the expression of SETBP1, coding for an important cancer gene located on chromosome 18 that is observed also as a predominant hotspot in figure 3 c. Somatic mutations in SETBP1 [44] , as well as its expression patterns [45] , are related with myeloid leukaemia disease. Moreover in figure 3 b, we observed a very predominant hotspot regarding three CpGs belonging to three different genes but all closely located on chromosome 6; Two of them (cg02622316 located on gene ZNF96 and cg02599464 located on gene HIST1H41 ) have already been published as hypermethylated in individuals with muscle-invasive bladder cancer [46] . The first one is positively associated with many SNPs and gene expression probes, and the second is positively and negatively associated with some SNPs and only positively with some gene expression probes.
A more detailed discussion of the potential biological findings than involved in triple relationships is beyond this particularly study and detailed results about all of the combinations are provided in online supplementary table 4.
The Integrative Framework
We built and propose a multi-staged omics integration framework whose application does not require a strong methodological knowledge, being easy and effective to use. The multi-staged framework we applied has the advantage of analyzing data of all subjects that overlap among pairs of data and is not restricted to only those few individuals with a complete overlap among all data types. Thus, we take advantage of more samples using this framework than integrating the data in a multi-dimensional model. Therefore, we show here, for the first time, the application of a multi-staged framework that allows us to (1) integrate more than two omics data for the same set of individuals; (2) dissect the biological relationships that may point to new mechanisms involved in the development/ progression of UBC through a hypothesis-based model built step by step, and (3) envision the complexities of the general scenario of genomic regulation.
Conclusions
While these results are exciting, we acknowledge the following limitations. First, in this study, we use the 27K methylation array that only covers a selection of CpG sites making it infeasible to replicate previous reported findings using the 450K array. Second, statistical power is a commonplace in any QTL analysis, given the extensive amount of data analyzed and the small sample size. While this limitation needs to be considered in the interpretation of the results, it is worth mentioning that even a large enough size will unlikely be able to meet the standard criteria of statistical power; therefore, our study represents a proof of concept in the integrative omics field. In addition, while we might not be able to address unmeasured confounding factors, no differences were found between the demographic factors and methylation and gene ex- 135 pression in our series. A validation of these results, to discard false positive findings, is not trivial due to the multiple genomic factors, the models considered and the characteristics of the series. Despite these limitations, this study has several strengths. We have performed an analysis of tumour samples what gave us the opportunity to study in detail the regulation of three types of omics data in UBC, providing some evidences on the genomics regulation of the tumour. We have applied an easy, reproducible and detailed framework to perform an integrative study of the relationships between genetic variations, DNA methylation and gene expression, showing a whole spectrum of associations between them. We have shown that omics data integration helps unravelling biological mechanisms involved in UBC. All of these relations may help in the identification of new molecular targets to be further explored in detail, mainly regarding trans-relationships.
In conclusion, this study provides the scientific community with a pipeline to integrate more than two sets of omics data that can be applied in future analyses seeking to better understand the biology behind complex diseases. In addition, we highlight the importance of integrating omics data to identify new genetic mechanisms in UBC. While several pieces of evidences support our findings, they still require experimental validation to be considered conclusive.
